The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania - PubMed (original) (raw)
The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania
Robert Pool et al. Malar J. 2008.
Abstract
Background: Intermittent preventive treatment of malaria in infants (IPTi) reduces the incidence of clinical malaria. However, before making decisions about implementation, it is essential to ensure that IPTi is acceptable, that it does not adversely affect attitudes to immunization or existing health seeking behaviour. This paper reports on the reception of IPTi during the first implementation study of IPTi in southern Tanzania.
Methods: Data were collected through in-depth interviews, focus group discussions and participant observation carried out by a central team of social scientists and a network of key informants/interviewers who resided permanently in the study sites.
Results: IPTi was generally acceptable. This was related to routinization of immunization and resonance with traditional practices. Promoting "health" was considered more important than preventing specific diseases. Many women thought that immunization was obligatory and that health staff might be unwilling to assist in the future if they were non-adherent. Weighing and socialising were important reasons for clinic attendance. Non-adherence was due largely to practical, social and structural factors, many of which could be overcome. Reasons for non-adherence were sometimes interlinked. Health staff and "road to child health" cards were the main source of information on the intervention, rather than the specially designed posters. Women did not generally discuss child health matters outside the clinic, and information about the intervention percolated slowly through the community. Although there were some rumours about sulphadoxine pyrimethamine (SP), it was generally acceptable as a drug for IPTi, although mothers did not like the way tablets were administered. There is no evidence that IPTi had a negative effect on attitudes or adherence to the expanded programme on immunisation (EPI) or treatment seeking or existing malaria prevention.
Conclusion: In order to improve adherence to both EPI and IPTi local priorities should be taken into account. For example, local women are often more interested in weighing than in immunization, and they view vaccination and IPTi as vaguely "healthy" rather preventing specific diseases. There should be more emphasis on these factors and more critical consideration by policy makers of how much local knowledge and understanding is minimally necessary in order to make interventions successful.
Similar articles
- Community response to intermittent preventive treatment delivered to infants (IPTi) through the EPI system in Manhiça, Mozambique.
Pool R, Munguambe K, Macete E, Aide P, Juma G, Alonso P, Menendez C. Pool R, et al. Trop Med Int Health. 2006 Nov;11(11):1670-8. doi: 10.1111/j.1365-3156.2006.01725.x. Trop Med Int Health. 2006. PMID: 17054746 - Development of behaviour change communication strategy for a vaccination-linked malaria control tool in southern Tanzania.
Mushi AK, Schellenberg J, Mrisho M, Manzi F, Mbuya C, Mponda H, Mshinda H, Tanner M, Alonso P, Pool R, Schellenberg D. Mushi AK, et al. Malar J. 2008 Sep 29;7:191. doi: 10.1186/1475-2875-7-191. Malar J. 2008. PMID: 18823531 Free PMC article. - Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.
de Sousa A, Rabarijaona LP, Ndiaye JL, Sow D, Ndyiae M, Hassan J, Lambo N, Adovohekpe P, Guidetti F, Recht J, Affo A. de Sousa A, et al. Trop Med Int Health. 2012 Mar;17(3):308-15. doi: 10.1111/j.1365-3156.2011.02915.x. Epub 2011 Nov 29. Trop Med Int Health. 2012. PMID: 22128893 - The IPTi Consortium: research for policy and action.
Schellenberg D, Cisse B, Menendez C. Schellenberg D, et al. Trends Parasitol. 2006 Jul;22(7):296-300. doi: 10.1016/j.pt.2006.05.006. Epub 2006 May 19. Trends Parasitol. 2006. PMID: 16713739 Review. - Intermittent preventive therapy for malaria: progress and future directions.
Grobusch MP, Egan A, Gosling RD, Newman RD. Grobusch MP, et al. Curr Opin Infect Dis. 2007 Dec;20(6):613-20. doi: 10.1097/QCO.0b013e3282f1ae3b. Curr Opin Infect Dis. 2007. PMID: 17975412 Review.
Cited by
- When "Good Evidence" Is Not Enough: A Case of Global Malaria Policy Development.
D'Souza BJ, Parkhurst JO. D'Souza BJ, et al. Glob Chall. 2018 Mar 22;2(9):1700077. doi: 10.1002/gch2.201700077. eCollection 2018 Sep. Glob Chall. 2018. PMID: 31565347 Free PMC article. - Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.
Cairns M, Ghani A, Okell L, Gosling R, Carneiro I, Anto F, Asoala V, Owusu-Agyei S, Greenwood B, Chandramohan D, Milligan P. Cairns M, et al. PLoS One. 2011 Apr 20;6(4):e18947. doi: 10.1371/journal.pone.0018947. PLoS One. 2011. PMID: 21533088 Free PMC article. - Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea.
Pell C, Straus L, Phuanukoonnon S, Lupiwa S, Mueller I, Senn N, Siba P, Gysels M, Pool R. Pell C, et al. Malar J. 2010 Dec 22;9:369. doi: 10.1186/1475-2875-9-369. Malar J. 2010. PMID: 21176197 Free PMC article. Clinical Trial. - Prevention Efforts for Malaria.
Tizifa TA, Kabaghe AN, McCann RS, van den Berg H, Van Vugt M, Phiri KS. Tizifa TA, et al. Curr Trop Med Rep. 2018;5(1):41-50. doi: 10.1007/s40475-018-0133-y. Epub 2018 Feb 8. Curr Trop Med Rep. 2018. PMID: 29629252 Free PMC article. Review.
References
- Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M, Mshinda H, Alonso P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet. 2001;357:1471–1477. doi: 10.1016/S0140-6736(00)04643-2. - DOI - PubMed
- Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N, Jaffar S, Baiden R, Hodgson A, Binka F, Greenwood B. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ. 2005;331:727–733. doi: 10.1136/bmj.331.7519.727. - DOI - PMC - PubMed
- Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, Sigauque B, Dobaño C, Mabunda S, DgeDge M, Alonso P, Menendez C. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis. 2006;194:276–85. doi: 10.1086/505431. - DOI - PubMed
- Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson PA, Abruquah HH, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer CG, Adjei O, May J. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis. 2007;45:16–25. doi: 10.1086/518575. - DOI - PubMed
- Mockenhaupt FP, Reither K, Zanger P, Roepcke F, Danquah I, Saad E, Ziniel P, Dzisi SY, Frempong M, Agana-Nsiire P, Amoo-Sakyi F, Otchwemah R, Cramer JP, Anemana SD, Dietz E, Bienzle U. Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, and placebo-controlled trial in northern Ghana. Antimicrob Agents Chemother. 2007;51:3273–81. doi: 10.1128/AAC.00513-07. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical